Curis Lifesciences Ltd.
CURIS
Curis Lifesciences Ltd.
CURIS
Curis Lifesciences Ltd. Share Price
199.00 0.00 (0.00%)Share Price Today – Curis Lifesciences Ltd.
As of October 16, 2026, Curis Lifesciences Ltd. share price is ₹199.00. The stock opened at ₹0.00 and closed at ₹199.00 in the previous session. Over the last 52 weeks, the stock has recorded a low of ₹83.60 and a high of ₹234.75. In terms of performance, the stock has delivered 77.5% returns over the past six months and 55.5% returns over the last year.
About the company
Fundamentals
Market Cap₹161Cr | EPS₹10.26 |
P/E Ratio (TTM)23.43 | Industry P/E (TTM)45.10 |
P/B Ratio3.39 | Long Term D/E0.45 |
ROE21.65% | Dividend Yield (TTM)0.00% |
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Curis Lifesciences Ltd.
The share price of Curis Lifesciences Ltd. is ₹199.00 on NSE as of 16/10/2026, 10:23:16 pm. Share prices may change frequently due to market movements.
The market capitalisation of Curis Lifesciences Ltd. is ₹161Cr as of 16/10/2026, 10:23:16 pm
The current Price to Earnings (P/E) ratio of Curis Lifesciences Ltd. is 23.43 as of 16/10/2026, 10:23:16 pm
The Price to Book (P/B) ratio of Curis Lifesciences Ltd. stands at 3.40 as of 16/10/2026, 10:23:16 pm
Curis Lifesciences Ltd. reported an ROE of 21.66% for the last reported financial year on a consolidated account basis.
As of 16/10/2026, 10:23:16 pm, Curis Lifesciences Ltd.’s shareholding pattern is: promoters hold 68.00%, FIIs hold 1.20%, DIIs hold 5.80%, and public shareholders hold 25.00%.
The 52-week high of Curis Lifesciences Ltd. is ₹234.75 and the 52-week low is ₹83.60 as of 16/10/2026, 10:23:16 pm.
The earnings per share (EPS) of Curis Lifesciences Ltd. is -- for the quarter ended Sep 2026.
The stock symbol of Curis Lifesciences Ltd. is CURIS.
You can buy Curis Lifesciences Ltd. shares by opening a demat and trading account with PhonePe Invest and placing a buy order on NSE or BSE during market hours.
The fair value of Curis Lifesciences Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Earnings Per Share
Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 60.63 | +23.41% |
| Other Income | 0.28 | -45.10% |
| Total Income | 60.91 | +22.70% |
| Total Expenditure | 51.33 | +24.05% |
| EBIDT | 11.41 | +13.53% |
| Depreciation | 0.70 | +4.48% |
| Interest | 1.14 | +2.70% |
| Tax | 2.65 | +22.69% |
| Net Profit | 6.92 | +13.26% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 69.14 |
| Total Non-Current Assets | 12.38 |
| Fixed assets | 12.10 |
| Total Assets | 81.52 |
| Total Current liabilities | 27.40 |
| Total Non Current Liabilities | 6.76 |
| Total Equity Plus Liabilities | 81.52 |
| Total Shareholder Funds | 47.36 |
| Total Debt to Equity | 46.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | -16.42 |
| Cash from Financing Activities | 20.87 |
| Cash from Investing Activities | -1.59 |
| Net Cash Flow | 2.86 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages12
Bearish Moving Averages4
5 Day
193.2010 Day
205.2020 Day
206.4030 Day
192.0050 Day
160.90100 Day
137.50150 Day
125.50200 Day
124.30Indicators
RSI (14)
54.22MACD (12, 26)
8.68MACD Signal Line (9)
14.67MFI (14)
49.63ATR (14)
9.34ADX (14)
43.73ROC (21)
-8.99ROC (125)
113.98Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Curis Lifesciences Ltd.
CURIS
Open Price | 0.00 |
Previous Close | 199.00 |
Volume | 0 |
Average Price | 197.23 |
Upper Circuit | 208.95 |
Lower Circuit | 189.05 |
Historical Performance
| NA | 1 Day |
| NA | 5 Days |
| NA | 1 Month |
| NA | 3 Months |
| NA | 1 Year |
| NA | 5 Years |
| NA | 10 Years |